Login
TAKEDA PHARMACEUTICAL CO LTD logo

TAKEDA PHARMACEUTICAL CO LTD

takeda.com

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.

Financial Snapshot

Revenue
TTM
$4619B
Gross Margin
TTM
65.45%
Net Income
TTM
$180.7B
Current Assets
2026 Q2
$3150B
Current Liabilities
2026 Q2
$2765B
Current Ratio
2026 Q2
113.95%
Total Assets
2026 Q2
$15660B
Total Liabilities
2026 Q2
$8105B
Book Value
2026 Q2
7558B
Cash
2026 Q2
$461.0B
P/E
TTM
52.18
Free Cash Flow
TTM
$514.5B

Stock Price

Loading...
Market Cap: $9.4297 Trillion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support